Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P90
Near historical high
vs 2Y Ago
2.1x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 40.40% |
| Q2 2025 | 4.87% |
| Q1 2025 | 4.38% |
| Q4 2024 | 10.56% |
| Q3 2024 | 12.91% |
| Q2 2024 | 3.85% |
| Q1 2024 | -30.57% |
| Q4 2023 | 16.32% |
| Q3 2023 | 19.68% |
| Q2 2023 | 31.36% |
| Q1 2023 | -67.57% |
| Q4 2022 | -1.47% |
| Q3 2022 | -26.82% |
| Q2 2022 | -131.81% |
| Q1 2022 | 59.12% |
| Q4 2021 | -73.21% |
| Q3 2021 | -9.39% |
| Q2 2021 | 17.11% |
| Q1 2021 | 13.12% |
| Q4 2020 | -62.42% |
| Q3 2020 | -0.62% |
| Q2 2020 | 8.88% |
| Q1 2020 | -55.08% |
| Q4 2019 | 40.25% |
| Q3 2019 | 19.40% |
| Q2 2019 | -116.26% |
| Q1 2019 | -7.91% |
| Q4 2018 | -95.02% |
| Q3 2018 | 42.71% |
| Q2 2018 | 38.55% |
| Q1 2018 | -49.26% |
| Q4 2017 | -299.49% |
| Q3 2017 | 79.77% |
| Q2 2017 | 11.15% |
| Q1 2017 | -122.75% |
| Q4 2016 | 52.70% |
| Q3 2016 | -8.26% |
| Q2 2016 | 6.26% |
| Q1 2016 | -33.15% |
| Q4 2015 | 7.21% |